Published in Gene Therapy Weekly, July 7th, 1997
Under the terms of this extension, Algene undertakes a series of gene mapping experiments to identify chromosomal regions that could harbor causal genes in schizophrenia.
In the framework of the collaboration originally established in 1995 with Janssen, Algene applied its technology platform to select cases of schizophrenia and to initiate causal gene mapping experimentation. A first...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.